Isansys Lifecare Ltd, the provider of complete real-time physiological patient status systems and services, has today announced that it will be attending and presenting at BioTrinity 2015 company showcase, Europe’s leading Biopartnering and Investment Conference, to be held on 11-13 May at the Novotel London West.
During the three-day event, Keith Errey, CEO of Isansys Lifecare, will be opening the MediTrinity company showcase sessions with a presentation entitled “More Than Patient Monitoring – Towards Data Driven Precision Healthcare”. This theme and its relevance to clinical practice and patient safety in particular is supported by a poster from Isansys: “Data driven healthcare – Digital diagnostics and new methods for improved patient safety” in the poster presentation sessions.
This UK Innovation poster presentation, sponsored by the Oxford Academic Health Science Network (AHSN), follows the work of Isansys to address critical patient safety issues and enable improved patient monitoring and alerting both in hospital and at home.
Isansys Lifecare Ltd is a new generation healthcare company that provides patient surveillance and monitoring services built on an innovative, low cost and scalable digital platform.
A SBRI Healthcare funded company, based in Abingdon, Oxfordshire, is working with a number of hospitals in the NHS and other leading healthcare professionals and institutes to deliver patient monitoring services and patient status solutions using the Patient Status Engine (PSE) platform and new generation wireless vital signs monitors.
The PSE provides a complete end-to-end platform to continuously and wirelessly capture, collect, interpret and securely store vital sign and other physiological data. It incorporates a range of unobtrusive wearable sensors including the Lifetouch cardiac monitor, a wireless ‘smart patch’ that collects data directly from the patient and analyses every heartbeat to provide continuous heart rate, respiration rate and heart rate variability; the Lifetemp, a continuous wireless clinical thermometer, a continuous wireless pulse oximeter and a wireless blood pressure monitor.
Isansys is currently getting ready to launch the PSE2, its second generation wireless patient digitisation platform which incorporates the accumulated learning and feedback from hundreds of doctors, nurses and patients, and will significantly improve patient monitoring and provide robust data and timely early warning indicators both in hospital and at home. This second generation system will be launched at the end of this month.
Keith said: “There is a pressing need to improve patient safety, the way patients are monitored and how patients’ data is collected and analysed. Remote monitoring systems that use wireless, sensing and information technologies to collect and analyse patient data show great promise in delivering better care, improving patient safety and enhancing clinical outcomes. These technologies can also help reduce the costs associated with avoidable patient deterioration, medical errors, readmissions to intensive care wards and admissions (and readmissions) to hospital.
“We are looking forward to talking to the numerous life sciences companies and investors at the conference about our PSE2 platform and its capabilities.”
To find out more about Isansys’ second generation systems, or to book a free demonstration, please visit us in the Foyer of the Mezzanine Floor in the Novotel London West from 11.30am to 1.30pm on the 12th and 13th May. Alternatively, visit www.isansys.com, or call us on 01235 436229 for more information.